208 related articles for article (PubMed ID: 15990752)
1. The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis.
Pamukcu B; Oflaz H; Nisanci Y
Am Heart J; 2005 Apr; 149(4):675-80. PubMed ID: 15990752
[TBL] [Abstract][Full Text] [Related]
2. Impact of genetic polymorphisms on platelet function and aspirin resistance.
Pamukcu B; Oflaz H; Onur I; Hancer V; Yavuz S; Nisanci Y
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):53-6. PubMed ID: 19923980
[TBL] [Abstract][Full Text] [Related]
3. Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms.
Macchi L; Christiaens L; Brabant S; Sorel N; Ragot S; Allal J; Mauco G; Brizard A
J Am Coll Cardiol; 2003 Sep; 42(6):1115-9. PubMed ID: 13678940
[TBL] [Abstract][Full Text] [Related]
4. Anti-thrombotic action of clopidogrel and P1(A1/A2) polymorphism of beta3 integrin in patients with coronary artery disease not being treated with aspirin.
Dropinski J; Musial J; Jakiela B; Wegrzyn W; Sanak M; Szczeklik A
Thromb Haemost; 2005 Dec; 94(6):1300-5. PubMed ID: 16411409
[TBL] [Abstract][Full Text] [Related]
5. Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists.
Michelson AD; Furman MI; Goldschmidt-Clermont P; Mascelli MA; Hendrix C; Coleman L; Hamlington J; Barnard MR; Kickler T; Christie DJ; Kundu S; Bray PF
Circulation; 2000 Mar; 101(9):1013-8. PubMed ID: 10704169
[TBL] [Abstract][Full Text] [Related]
6. Does glycoprotein IIIa gene (Pl(A)) polymorphism influence clopidogrel resistance? : a study in older patients.
Papp E; Havasi V; Bene J; Komlosi K; Talian G; Feher G; Horvath B; Szapary L; Toth K; Melegh B
Drugs Aging; 2007; 24(4):345-50. PubMed ID: 17432927
[TBL] [Abstract][Full Text] [Related]
7. Defective platelet response to arachidonic acid and thromboxane A(2) in subjects with Pl(A2) polymorphism of beta(3) subunit (glycoprotein IIIa).
Andrioli G; Minuz P; Solero P; Pincelli S; Ortolani R; Lussignoli S; Bellavite P
Br J Haematol; 2000 Sep; 110(4):911-8. PubMed ID: 11054082
[TBL] [Abstract][Full Text] [Related]
8. The role of exercise on platelet aggregation in patients with stable coronary artery disease: exercise induces aspirin resistant platelet activation.
Pamukcu B; Oflaz H; Acar RD; Umman S; Koylan N; Umman B; Nisanci Y
J Thromb Thrombolysis; 2005 Aug; 20(1):17-22. PubMed ID: 16133890
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of the platelet glycoprotein IIIa Pl(A1/A2) polymorphism in three South African ethnic groups and its effect on platelet function.
Naran NH; Chetty N; Crowther NJ
Thromb Res; 2008; 123(2):316-23. PubMed ID: 18657307
[TBL] [Abstract][Full Text] [Related]
10. Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination.
Cooke GE; Liu-Stratton Y; Ferketich AK; Moeschberger ML; Frid DJ; Magorien RD; Bray PF; Binkley PF; Goldschmidt-Clermont PJ
J Am Coll Cardiol; 2006 Feb; 47(3):541-6. PubMed ID: 16458133
[TBL] [Abstract][Full Text] [Related]
11. The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events.
Pamukcu B; Oflaz H; Oncul A; Umman B; Mercanoglu F; Ozcan M; Meric M; Nisanci Y
J Thromb Thrombolysis; 2006 Oct; 22(2):103-10. PubMed ID: 17008975
[TBL] [Abstract][Full Text] [Related]
12. Aspirin resistance in cerebrovascular disease and the role of glycoprotein IIIa polymorphism in Turkish stroke patients.
Derle E; Öcal R; Kibaroğlu S; Çelikkol C; Bayraktar N; Verdi H; Ataç BF; Can U
Blood Coagul Fibrinolysis; 2016 Mar; 27(2):169-75. PubMed ID: 26809135
[TBL] [Abstract][Full Text] [Related]
13. Effect of the Pl(A2) alloantigen on the function of beta(3)-integrins in platelets.
Bennett JS; Catella-Lawson F; Rut AR; Vilaire G; Qi W; Kapoor SC; Murphy S; FitzGerald GA
Blood; 2001 May; 97(10):3093-9. PubMed ID: 11342435
[TBL] [Abstract][Full Text] [Related]
14. PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement.
Kastrati A; Koch W; Gawaz M; Mehilli J; Böttiger C; Schömig K; von Beckerath N; Schömig A
J Am Coll Cardiol; 2000 Jul; 36(1):84-9. PubMed ID: 10898417
[TBL] [Abstract][Full Text] [Related]
15. Platelet glycoprotein IIIa Pl(a) polymorphism, fibrinogen, and platelet aggregability: The Framingham Heart Study.
Feng D; Lindpaintner K; Larson MG; O'Donnell CJ; Lipinska I; Sutherland PA; Mittleman M; Muller JE; D'Agostino RB; Levy D; Tofler GH
Circulation; 2001 Jul; 104(2):140-4. PubMed ID: 11447076
[TBL] [Abstract][Full Text] [Related]
16. The GPIIIa PlA polymorphism and the platelet hyperactivity in Tunisian patients with stable coronary artery disease treated with aspirin.
Abderrazek F; Chakroun T; Addad F; Dridi Z; Gerotziafas G; Gamra H; Hassine M; Elalamy I
Thromb Res; 2010 Jun; 125(6):e265-8. PubMed ID: 20138334
[TBL] [Abstract][Full Text] [Related]
17. Association of CYP2C19, CYP3A5 and GPIIb/IIIa gene polymorphisms with Aspirin and Clopidogrel Resistance in a cohort of Indian patients with Coronary Artery Disease.
Arya V; Mahajan P; Saraf A; Mohanty A; Sawhney JP; Bhargava M
Int J Lab Hematol; 2015 Dec; 37(6):809-18. PubMed ID: 26264906
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the serum sCD40L level and aspirin-resistant platelet aggregation in patients with stable coronary artery disease.
Pamukcu B; Oflaz H; Onur I; Midilli K; Yilmaz G; Yilmaz E; Nisanci Y
Circ J; 2008 Jan; 72(1):61-6. PubMed ID: 18159101
[TBL] [Abstract][Full Text] [Related]
19. Effect of high dose statin therapy on platelet function; statins reduce aspirin-resistant platelet aggregation in patients with coronary heart disease.
Tirnaksiz E; Pamukcu B; Oflaz H; Nisanci Y
J Thromb Thrombolysis; 2009 Jan; 27(1):24-8. PubMed ID: 17917708
[TBL] [Abstract][Full Text] [Related]
20. The impact of genetic variation in the region of the GPIIIa gene, on Pl expression bias and GPIIb/IIIa receptor density in platelets.
O'Halloran AM; Curtin R; O'Connor F; Dooley M; Fitzgerald A; O'Brien JK; Fitzgerald DJ; Shields DC
Br J Haematol; 2006 Feb; 132(4):494-502. PubMed ID: 16412022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
